PharVision Advisers’s Healthcare Realty HR Stock Holding History

PharVision Advisers’s Portfolio HR Stock Details HR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,818	Closed	-$200K	–	351
2025 Q4	$200K	Buy	+11,818	New	+$210K	0.1%	558

Other funds holding HR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Resolution Capital Sydney, NSW, Australia $5.44B AUM 27.71% 1-Year Est. Return

AAMU

APG Asset Management US New York $14.3B AUM 16.79% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PharVision Advisers's HR Position: Q1 2026 in Review

PharVision Advisers sold out of Healthcare Realty (HR) in Q1 2026, closing a stake of 11,818 shares — an estimated $200K sold.

PharVision Advisers first reported a position in HR in Q4 2025 and held it in 1 quarter. The position peaked at $200K in Q4 2025. 448 funds tracked by Wall St. Rank hold HR as of Q1 2026.

PharVision Advisers reported no remaining Healthcare Realty position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 11,818 Healthcare Realty shares in Q1 2026, an estimated $200K.
PharVision Advisers first reported a position in Healthcare Realty in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Healthcare Realty position peaked at $200K in Q4 2025.
448 funds tracked by Wall St. Rank held Healthcare Realty as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.